Kinnate Biopharma Inc.
Healthcare · Pharmaceutical Preparations · DE · SEC filings ↗ · Compare ⊕
Financials
SEC XBRL · annual| FY23 | FY22 | FY21 | FY20 | |
|---|---|---|---|---|
| Revenue | — | — | — | — |
| Operating income | −$121.2M | −$118.5M | −$90.1M | −$36.0M |
| Net income | −$112.6M | −$116.3M | −$89.8M | −$35.8M |
| Total assets | $173.6M | $278.8M | $366.9M | $400.6M |
| Total liabilities | $14.3M | $20.4M | $12.4M | — |
| Equity | $159.3M | $223.5M | $319.5M | $393.3M |
| EPS (diluted) | $-2.42 | $-2.64 | $-2.06 | $-5.28 |
| Shares out. | 46.6M | 43.9M | 43.9M | 43.5M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2023- Operating margin
- —
- Net margin
- —
- Return on equity
- −70.7%
- Return on assets
- −64.9%
- Return on capital (ROCE)
- −75.0%
- Liabilities / assets
- 8.2%
- Debt / equity
- 0.09×
- Book value / share
- $3.42
- Revenue growth (YoY)
- —
- Net income growth (YoY)
- —
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2023- Altman Z″ (distress)
- 5.56safe
- Accruals / assets
- −7.3%clean
- Piotroski F-Score
- 1/7weak
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.
Signs
● 1 warning● 3 good- Negative operating cash flow
- Conservative leverage (liabilities < 50% of assets)
- Clean earnings (low accruals)
- Altman Z″ in the safe zone
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Insider transactions
SEC Form 4 · most recent| Insider | Date | Type | Shares | Price |
|---|---|---|---|---|
| Tananbaum James B.Director | Apr 3, 2024 | D | 9.7M | — |
| Farzan NimaOfficer — CHIEF EXECUTIVE OFFICER | Apr 3, 2024 | D | 2,186 | — |
| Krishnamohan NehaOfficer — CHIEF FINANCIAL OFFICER | Apr 3, 2024 | D | 64,087 | — |
| Flaherty Keith T.Director | Apr 3, 2024 | D | 66,377 | — |
| Meltz Mark AOfficer — COO GENERAL COUNSEL SECRETARY | Apr 3, 2024 | D | 27,578 | — |
| Gordon Carl LDirector | Apr 3, 2024 | D | 1.4M | — |
Headline trade per Form 4 (officers, directors, 10%+ owners). Buy/sell read from the filing's structured data — blank where a field isn't cleanly tagged.
Material events
SEC Form 8-K · most recent- Completed an acquisition or disposition · Delisting / listing-standard notice · Modified shareholder rights · Change in control · Director / officer change · Amended charter or bylaws · Other material eventApr 3, 2024
- Entered a material agreement · Completed an acquisition or disposition · Regulation FD disclosureMar 1, 2024
- Entered a material agreement · Regulation FD disclosureFeb 16, 2024
- Regulation FD disclosureJan 16, 2024
- Director / officer changeNov 22, 2023
- Other material eventNov 15, 2023
- Results of operationsNov 9, 2023
- Results of operations · Costs from exit or disposal · Regulation FD disclosureSep 18, 2023
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗Event-driven situations (1)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.